GLDD, CIEN and PODD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 31, 2025.

Osaic Holdings Inc. boosted its position in Insulet Corporation (NASDAQ: PODD) by 152.9% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,781 shares of the medical instruments supplier's stock after acquiring an additional 5,309 shares during the period. Osaic

Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Central Pacific Bank Trust Division lowered its stake in shares of Insulet Corporation (NASDAQ: PODD) by 99.8% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 480 shares of the medical instruments supplier's stock after selling 291,000 shares during the quarter. Central Pacific

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 11:15 a.m. (Pacific Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation:.

ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026.

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod brand of products, has announced the expansion of its U.S. Pod recycling program, which is now available to all U.S. customers. “Here at Insulet, our mission is to transform the lives of people with diabetes, and we are equally committed to creating a more sustainable future,” said Carolyn Sleeth, Senior Vice President and U.S. Ge.

Geneos Wealth Management Inc. lowered its stake in shares of Insulet Corporation (NASDAQ: PODD) by 9.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,265 shares of the medical instruments supplier's stock after selling 3,253 shares during the

Frontier Capital Management Co. LLC boosted its stake in Insulet Corporation (NASDAQ: PODD) by 3.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 91,547 shares of the medical instruments supplier's stock after buying an additional 2,683 shares during the period. Frontier